In the specialized field of molecular biology IKZF1 Peptideis used for blocking the activity of IKZF1 antibody(catalog number 42-782). The IKZF1 antibody ships at 0.5 mg/mL and the IKZF1 Peptide ships as Read more research, the IKZF peptide serves as a vital tool for investigators working with the Ikaros family of zinc-finger proteins. My experience with these reagents has shown that they are indispensable for validating the specificity of antibody bin IKK Alpha Peptide – Solution – 50 µg ding in various experimental workflows.
The Role of the IKZF Family
The IKZF family represents a group of transcription factor families, including IKZF1 (Ikaros), IKZF2 (Helios), and IKZF3 (Aiolos). These proteins play a crucial role in processes such as lymphopoiesis, differentiation, and functional regulation. Because they are central to these complex biological pathways, researchers often require highly specific antibodies to detect them. This is where the blocking peptide becomes a cornerstone of experimental integrity.
How the IKZF Peptide Functions
A blocking peptide is a synthetic peptide designed for use in combination with an anti-IKZF1 antibody. In my laboratory work, I have found that these peptides are essential when performing western blot or immunohistochemistry validation. Essentially, these are peptides that bind specifically to the target antibody a Function: Blocking peptides arepeptides that bind specifically to the target antibody and block antibody binding. These peptide usually contains the epitope Read more nd block antibody binding. By pre-incubating the antibody with the corresponding peptide, any signal observed in an assay can be confirmed as genuine, rather than the result of non-specific binding.
For example, the IKZF1 protein is a transcription factor of the ikaros C2H2-type zinc-finger protein family. When using an antibody to detect this protein, the peptide acts as a competitive inhibitor. If the signal disappears when the antibody i IKZF1 Peptide - Cat. No. 42-782P s pre-incubated with the peptide, it indicates that the antibody is successfully targeting the intended epitope.
Technical Applications and Variations
My ex Degradation of IKZF1 prevents epigenetic progression of T ploration of these materials has involved various specific configurations:
* IKZF1 Antibody Validation: A standard IKZF1 peptide is used for blocking the activity of the IKZF1 antibody. These reagents are often supplied in lyophilized forms or concentrated solutions (e.g., 0.5 mg/mL) to ensure stability during transport and storage.
* Targeted Degradation Research: Beyond simple blocking, the field is evolving. The IKZF1/3 ligand-1 is a PROTAC target protein ligand that researchers utilize for the synthesis of targeted protein degraders. This represents a more advanced application compared to traditional blocking, as it involves the chemical manipulation of protein stability.
* Structural Studies: I have also encountered specialized sequences, such as the IKZF3 (144–168) polypeptide, which has been studied for its properties as a peptidic degron. These specific fragments allow for a deeper understanding of how these proteins interact with E3 ligases.
* Comparative Research: While my primary focus has been on Ikaros, I have occasionally utilized the IKK alpha peptide as a control or a comparative reagent when investigating broader signaling pathways involving the IKK complex.
Best Practices for Researchers
When integrating The many faces of IKZF1 in B-cell precursor acute lymphoblastic these tools into your own research, consider the following:
1. Specificity: Always ensure that the peptide matches the precise epitope of your antibody. Using a generic sequence will not provide the necessary validation.
2. Storage: Most peptides are sensitive to repeated freeze-thaw cycles. I recommend aliquoting them upon arrival to maintain purity and functionality.
3. by V Koduri·2019·Cited by 71—TheIKZF3 (144–168) polypeptidedid not function as a degron when fused to the N terminus of GFP (SI Appendix, Fig. S3). Finally, this Read more Documentation: Keep detailed logs of the concentration ratios used in your blocking experiments. A 5:1 or 10:1 ratio of peptide to antibody is common in my workflow, but this should be optimized based on the specific antibody’s affinity.
By utilizing high-quality IKZF peptide reagents, one can significantly improve the reproducibility of experimental data. Whether you are investigating the transcription factor's role in differentiation or testing new molecular degradation strategies, these peptides remain the gold standard for antibody verification.